Global Inhalation Anesthetic Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Inhalation Anesthetic Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Inhalation Anesthetic report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Inhalation Anesthetic market is projected to reach US$ 1524.1 million in 2034, increasing from US$ 1244.1 million in 2022, with the CAGR of 2.9% during the period of 2024 to 2034. Demand from Hospital Use and Clinic Use are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Inhalation Anesthetic industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Inhalation Anesthetic key manufacturers include AstraZeneca, Fresenius-Kabi, BbVie Laboratories, Baxter Healthcare, Braun, Maruishi, Piramal Healthcare, Hikma Pharmaceuticals and Mylan, etc. AstraZeneca, Fresenius-Kabi, BbVie Laboratories are top 3 players and held % sales share in total in 2022.
Inhalation Anesthetic can be divided into Sevoflurane, Isoflurane, Desflurane and Others, etc. Sevoflurane is the mainstream product in the market, accounting for % sales share globally in 2022.
Inhalation Anesthetic is widely used in various fields, such as Hospital Use and Clinic Use, etc. Hospital Use provides greatest supports to the Inhalation Anesthetic industry development. In 2022, global % sales of Inhalation Anesthetic went into Hospital Use filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Inhalation Anesthetic market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report

AstraZeneca
Fresenius-Kabi
BbVie Laboratories
Baxter Healthcare
Braun
Maruishi
Piramal Healthcare
Hikma Pharmaceuticals
Mylan
Nhwa
Lunan
Hengrui
Anesthesia Reclamation
Deltasorb Technologies (Blue Zone Technology)
Segment by Type
Sevoflurane
Isoflurane
Desflurane
Others
Hospital Use
Clinic Use
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Inhalation Anesthetic market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Inhalation Anesthetic, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Inhalation Anesthetic industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Inhalation Anesthetic in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Inhalation Anesthetic introduction, etc. Inhalation Anesthetic Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Inhalation Anesthetic market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
North America, Europe and Asia Pacific are the key regions for Inhalation Anesthetic industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Inhalation Anesthetic key manufacturers include AstraZeneca, Fresenius-Kabi, BbVie Laboratories, Baxter Healthcare, Braun, Maruishi, Piramal Healthcare, Hikma Pharmaceuticals and Mylan, etc. AstraZeneca, Fresenius-Kabi, BbVie Laboratories are top 3 players and held % sales share in total in 2022.
Inhalation Anesthetic can be divided into Sevoflurane, Isoflurane, Desflurane and Others, etc. Sevoflurane is the mainstream product in the market, accounting for % sales share globally in 2022.
Inhalation Anesthetic is widely used in various fields, such as Hospital Use and Clinic Use, etc. Hospital Use provides greatest supports to the Inhalation Anesthetic industry development. In 2022, global % sales of Inhalation Anesthetic went into Hospital Use filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Inhalation Anesthetic market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report

By Company
AstraZeneca
Fresenius-Kabi
BbVie Laboratories
Baxter Healthcare
Braun
Maruishi
Piramal Healthcare
Hikma Pharmaceuticals
Mylan
Nhwa
Lunan
Hengrui
Anesthesia Reclamation
Deltasorb Technologies (Blue Zone Technology)
Segment by Type
Sevoflurane
Isoflurane
Desflurane
Others
Segment by Application
Hospital Use
Clinic Use
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Inhalation Anesthetic market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Inhalation Anesthetic, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Inhalation Anesthetic industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Inhalation Anesthetic in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Inhalation Anesthetic introduction, etc. Inhalation Anesthetic Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Inhalation Anesthetic market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
